Publications by authors named "Ubezio M"

: Postoperative cerebrospinal fluid (CSF) fistulas remain a significant concern in spinal neurosurgery, particularly following dural closure. The incidence of dural tears during spinal surgery is estimated between 1.6% and 10%.

View Article and Find Full Text PDF

Samples from 34 adult patients newly diagnosed with core binding factor leukemia (CBFL) were collected both at the time of diagnosis and at relapse and were centrally analyzed. Eligible patients received either standard induction CT known as "3 + 7" or an equivalent regimen, according to the recruiting center's policy. Patients who achieved CR or CRi received 3 courses of high-dose ARA-C (Cytarabine) 3000 mg/m every 12 h on days 1, 3, and 5, along with midostaurin at the dose of 50 mg b.

View Article and Find Full Text PDF

Lombardy represents the largest region of Italy by population, with almost 10 million residents, a dimension similar to a medium size country like Sweden or Belgium. The CML subcommittee of the Lombardy Hematology Network (REL-CML) conducted a study at the beginning of 2023. Prevalence was calculated by direct input from the 21 centers participating in REL-CML.

View Article and Find Full Text PDF

Introduction: Chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or mutation (MDS-RS/) differ in many clinical features, but share others, such as anemia. RS and mutation can also be found in CMML.

Methods: We compared CMML with and without RS/ and MDS-RS/ considering the criteria established by the 2022 World Health Organization classification.

View Article and Find Full Text PDF

Objective: The development of specific clinical and neurological symptoms and radiological degeneration affecting the segment adjacent to a spinal arthrodesis comprise the framework of adjacent-level syndrome. Through the analysis of a large surgical series, this study aimed to identify possible demographic, clinical, radiological, and surgical risk factors involved in the development of adjacent-level syndrome.

Methods: A single-center retrospective analysis of adult patients undergoing lumbar fusion procedures between January 2014 and December 2018 was performed.

View Article and Find Full Text PDF

Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) chacaterized by persistent peripheral blood monocytosis, hypercellular bone marrow and dysplasia at least in one myeloid lineage. CMML shares much of its molecular landscape with other myeloid neoplasms, while differs from others such as chronic neutrophilic leukemia (CNL), given the high frequency of CSF3R mutations in the latter. In this article, we report a case of CSF3R-mutated CMML and dissect this rare entity by reviewing the medical literature, with the intent to understand how this rare mutation shapes CMML's clinical and morphological phenotype.

View Article and Find Full Text PDF
Article Synopsis
  • Synthetic data are artificial datasets generated using algorithms that learn from real patient data, aiming to preserve privacy while accelerating research in life sciences, specifically in hematologic neoplasms.
  • The study utilized a conditional generative adversarial network to create high-fidelity synthetic data for conditions like myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), validating the data's accuracy and privacy through a robust framework.
  • Results showed that synthetic data could significantly augment existing clinical data, enhance research capabilities, and allow for the development of new molecular classification and scoring systems, ultimately benefiting clinicians through a user-friendly website for data generation.
View Article and Find Full Text PDF
Article Synopsis
  • Myelodysplastic syndromes (MDS) require a specialized treatment approach, and the new Molecular International Prognostic Scoring System (IPSS-M) aims to enhance predictions for patient outcomes compared to the older IPSS-R model.
  • A study of 2,876 patients revealed that IPSS-M significantly improved survival predictions and shifted risk classifications in nearly half of the patients, even those without detectable gene mutations.
  • The findings suggest IPSS-M could better identify patients suitable for hematopoietic stem cell transplantation, although its effectiveness in certain treatment responses remains limited; further research on other influencing factors is necessary.
View Article and Find Full Text PDF
Article Synopsis
  • Ruxolitinib (RUX) is a treatment for myelofibrosis (MF) but often loses effectiveness over time, leading to worse overall survival after stopping treatment.
  • The study identified key predictors of survival for RUX-treated MF patients, such as dose, spleen size change, and need for blood transfusions after 6 months of treatment.
  • A new prognostic model called Response to Ruxolitinib After 6 Months (RR6) was developed, categorizing patients into low, intermediate, and high-risk groups for survival, helping guide treatment decisions.
View Article and Find Full Text PDF

PBX1 regulates the balance between self-renewal and differentiation of hematopoietic stem cells and maintains proto-oncogenic transcriptional pathways in early progenitors. Its increased expression was found in myeloproliferative neoplasm (MPN) patients bearing the JAK2 mutation. To investigate if PBX1 contributes to MPN, and to explore its potential as therapeutic target, we generated the JP mouse strain, in which the human JAK2 mutation is induced in the absence of PBX1.

View Article and Find Full Text PDF
Article Synopsis
  • * In a study of 1,794 people aged 80+, about one-third had mutations that correlated with lower survival rates and the likelihood of developing myeloid neoplasms, especially with specific mutations (like JAK2, DNMT3A, TET2).
  • * A predictive model based on mutation profiles and red blood cell index abnormalities categorized individuals into three risk groups for developing myeloid neoplasms; additionally, unexplained cytopenia in this age group could indicate underlying myeloid ne
View Article and Find Full Text PDF

Purpose: Recurrently mutated genes and chromosomal abnormalities have been identified in myelodysplastic syndromes (MDS). We aim to integrate these genomic features into disease classification and prognostication.

Methods: We retrospectively enrolled 2,043 patients.

View Article and Find Full Text PDF

Dendritic cells (DCs) play a crucial role in initiating and shaping immune responses. The effects of DCs on adaptive immune responses depend partly on functional specialization of distinct DC subsets, and partly on the activation state of DCs, which is largely dictated by environmental signals. Fully activated immunostimulatory DCs express high levels of costimulatory molecules, produce pro-inflammatory cytokines, and stimulate T cell proliferation, whereas tolerogenic DCs express low levels of costimulatory molecules, produce immunomodulatory cytokines and impair T cell proliferation.

View Article and Find Full Text PDF

Allogeneic hematopoietic stem cell transplantation (allo-SCT) represents the only curative treatment for patients with myelodysplastic syndrome (MDS), but involves non-negligible morbidity and mortality. Crucial questions in clinical decision-making include the definition of optimal timing of the procedure and the benefit of cytoreduction before transplant in high-risk patients. We carried out a decision analysis on 1728 MDS who received supportive care, transplantation or hypomethylating agents (HMAs).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the genetic factors underlying myelodysplastic syndromes (MDS) and their impact on outcomes after allogeneic hematopoietic stem-cell transplantation (HSCT) in 401 patients.
  • A significant 87% of patients had oncogenic mutations, with mutations in ASXL1, RUNX1, and TP53 identified as key predictors of relapse and survival post-transplant.
  • The findings suggest that incorporating these genetic markers alongside the International Prognostic Scoring System (IPSS-R) can enhance patient prognostication and potentially improve treatment strategies.
View Article and Find Full Text PDF

5-Azacytidine is an effective therapy in high risk MDS and oligoblastic AML. This "real life" analysis was made on 185 patients treated with 5-azacytidine in 10 centers afferent to REL ("Rete Ematologica Lombarda"), a network in Lombardia region. The aim was to assess the influence of disease and comorbidity risk assessments on the survival.

View Article and Find Full Text PDF

Objectives: To assess the effects of active music therapy (MT) and individualized listening to music (LtM) on behavioral and psychological symptoms of dementia (BPSDs) in persons with dementia (PWDs).

Design: Randomized controlled trial.

Setting: Nine Italian institutions.

View Article and Find Full Text PDF
Article Synopsis
  • Research has advanced our understanding of the genetic factors in myelodysplastic syndromes (MDS) and related neoplasms by analyzing 308 patients to clarify genotype/phenotype relationships.
  • Findings indicate that MDS linked to SF3B1 mutations represents a distinct entity, while MDS with nonmutated SF3B1 displays different characteristics and genetic profiles.
  • The study highlights specific mutations associated with various clinical outcomes and suggests that a molecular classification for myeloid neoplasms is achievable, aiding in better diagnosis and treatment strategies.
View Article and Find Full Text PDF

The World Health Organization classification of myelodysplastic syndromes (MDS) is based on morphological evaluation of marrow dysplasia. We performed a systematic review of cytological and histological data from 1150 patients with peripheral blood cytopenia. We analyzed the frequency and discriminant power of single morphological abnormalities.

View Article and Find Full Text PDF

To analyze the unpredicted event of hematological improvement (HI) during iron-chelation therapy (ICT), we reviewed a series of 53 myelodysplastic patients with transfusion dependency in a retrospective study involving 8 centers afferent to the "Rete Ematologica Lombarda". According to the IWG response criteria published in the year 2000, we observed erythroid responses in 19 patients (35.1%), 5 major (9.

View Article and Find Full Text PDF

Somatic mutations of the RNA splicing machinery have been recently identified in myelodysplastic syndromes. In particular, a strong association has been found between SF3B1 mutation and refractory anemia with ring sideroblasts, a condition characterized by ineffective erythropoiesis and parenchymal iron overload. We studied the relationship between SF3B1 mutation, erythroid activity and hepcidin levels in myelodysplastic syndrome patients.

View Article and Find Full Text PDF